The Epidemiology of Lupus Erythematosus

  • Sònia Jiménez
  • Ricard Cervera
  • Miguel Ingelmo
  • Josep Font


Systemic Lupus Erythematosus Systemic Lupus Erythematosus Patient Cutaneous Manifestation Acanthosis Nigricans Subacute Cutaneous Lupus Erythematosus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abu-Shakra M, Urowitz MB, Gladman DD, Gough J (1995a) Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death. J Rheumatol 22:1259–1264PubMedGoogle Scholar
  2. Abu-Shakra M, Urowitz MB, Gladman DD, Gough J (1995b) Mortality studies in systemic lupus erythematosus. Results for a single center. II. Predictor variables for mortality. J Rheumatol 22:1265–1270PubMedGoogle Scholar
  3. Anstey A, Bastian I, Dunckley H, Currie BJ (1993) Systemic lupus erythematosus in Australian aberigines: high prevalence, morbidity and mortality. Aust N Z J Med 23:646–651PubMedGoogle Scholar
  4. Boumpas DT, Fessler BJ, Austin HA III, Balow JE, Kippel JH, Lockshin MD (1995) Systemic lupus erythematosus: emerging concepts. Part 2: Dermatologic and joint diaseas, the antiphospholipis syndrome, pregnancy and hormonal therapy, morbidity and mortality, and pathogenesis. Ann Intern Med 123:42–53PubMedGoogle Scholar
  5. Callen JP (1985) Systemic lupus erythematosus in patients with chronic cutaneous (discoid) lupus erythematosus. Clinical and laboratory findings in seventeen patients. J Am Acad Dermatol 12:278–288PubMedGoogle Scholar
  6. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, Domenech I, Aydintug AO, Jedryka-Goral A, de Ramon E, Galeazzi M, Haga HJ, Mathieu A, Houssiau F, Ingelmo M, Hughes GRV, and the European Working Party on Systemic Lupus Erythematosus (1993) Systemic lupus erythematosus: clinical and imunological patterns of disease in a cohort of 1000 patients. Medicine (Baltimore) 72:113–124PubMedGoogle Scholar
  7. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, Mejia JC, Aydintug AO, Chwalinska-Sadowska H, de Ramon E, Fernandez-Nebro A, Galeazzi M, Valen M, Mathieu A, Houssiau F, Caro N, Alba P, Ramos-Casals M, Ingelmo M, Hughes GR (2003) Morbidity and mortality in systemic lupus erythematosus during a 10-year period. A comparison of early and late manifestations in a cohort of 1000 patients. Medicine (Baltimore) 82:299–308CrossRefPubMedGoogle Scholar
  8. Drenkard C, Villa AR, Alarcón-Segovia D, Pérez-Vazquez ME (1994) Influence of the antiphospholipid syndrome in the survival of patients with systemic lupus erythematosus. J Rheumatol 21:1067–1072PubMedGoogle Scholar
  9. Dubois EL, Tuffanelli DL (1964) Clinical manifestations of SLE. Computer analysis of 520 cases. J Am Med Assoc 190:104–111Google Scholar
  10. Estes D, Christian C (1971) The natural history of systemic lupus erythematosus by prospective analysis. Medicine (Baltimore) 50:85–95PubMedGoogle Scholar
  11. Fessel WJ (1974) Systemic lupus erythematosus in the community: incidence, prevalence, outcome and first symptoms; the high prevalence in black women. Arch Intern Med 134:1027–1035CrossRefPubMedGoogle Scholar
  12. Font J, Cervera R (1993) 1982 revised criteria for classification of systemic lupus erythematosus-Ten years later. Lupus 2:339–341PubMedGoogle Scholar
  13. Font J, Pallarés L, Cervera R, Lopez-Soto A, Navarro M, Bosch X, Ingelmo M (1991) Systemic lupus erythematosus in the elderly: clinical and immunological characteristics. Ann Rheum Dis 50:702–705PubMedGoogle Scholar
  14. Font J, Pallarés L, Cervera R, Vivancos J, Lopez-Soto A, Herrero C, Darnell A, Torras A, Mirapeix E, del Olmo JA et al (1993) Lupus eritematoso sistémico: estudio clínico e inmunológico de 300 pacientes. Med Clin (BARC) 100:601–605Google Scholar
  15. Fries JF, Weyl S, Hellman HR (1974) Estimating prognosis in diasease activity. Am J Med 57:561–566CrossRefPubMedGoogle Scholar
  16. Fukase M (1980) The epidemiology of systemic lupus erythematosus in Japan. In: Fukase M (ed) Systemic lupus erythematosus. University Park Press, Baltimore S 3–10Google Scholar
  17. Gilliam JN, Sontheiner RD (1981) Distinctive cutaneous subsets in the spectrum of lupus erythematosus. J Am Acad Dermatol 4:471–475PubMedGoogle Scholar
  18. Ginzler EM, Diamond HS, Weiner M, Schlesinger M, Fries JF, Wasner C, Medsger TA Jr, Ziegler G, Klippel JH, Hadler NM, Albert DA, Hess EV, Spencer Green G, Grayzel A, Worth D, Hahn BH, Barnett EV (1982) A multicenter study of outcomes in systemic lupus erythematosus. I. Entry variables as predictors of prognosis. Arthritis Rheum 25:601–611PubMedGoogle Scholar
  19. Gladman DD (1996) Prognosis and treatment of systemic lupus erythematosus. Curr Op Rheumatol 8:430–437Google Scholar
  20. Gourley IS, Patterson CC, Bell AL (1997) The prevalence of systemic lupus erythematosus in Nothern Ireland. Lupus 6:399–403PubMedGoogle Scholar
  21. Grigor R, Edmons J, Lewkonia R, Bresnihan B, Hughes GR (1978) Systemic lupus erythematosus. A prospective analysis. Ann Rheum Dis 37:121–128PubMedGoogle Scholar
  22. Gripenberg M, Helve T (1991) Outcome of systemic lupus erythematosus. A study of 66 patients over 7 years with special reference to the predictive value of anti-DNA antibody detrminations. Scand J Rheumatol 20:104–109PubMedGoogle Scholar
  23. Gudmundsson S, Steisson K (1990) Systemic lupus erythematosus in Iceland 1975 though 1984. A nationwide epidemiological study in an unselected population. J Rheumatol 17:1162–1167PubMedGoogle Scholar
  24. Helve T (1985) Prevalenceand mortality rates of systemic lupus erythematosus and causes of death in SLE patients in Finland. Scand J Rheumatol 14:43–46PubMedGoogle Scholar
  25. Hochberg MC (1987) Prevalence of systemic lupus erythematosus in England and Wales, 1981–2. Ann Rheum Dis 46:664–666PubMedGoogle Scholar
  26. Hochberg MC, Perlmutter SL, Medsger TA, Steen V, Weisman MH, White B, Wigley FM (1995) Prevalence of self-reported physician-diagnosed systemic lupus erythematosus in the USA. Lupus 4:454–456PubMedGoogle Scholar
  27. Hopkinson ND, Doherty M, Powell RJ (1994) Clinical features and race-specific incidence/prevalence rates of systemic lupus erythematosus in geographically complete cohort of patients. Ann Rheum Dis 53:675–680PubMedGoogle Scholar
  28. Iseki K, Miyasato F, Oura T, Uehara H, Nishime K, Fukiyama K (1994) An epidemiologic analysis of end-stage lupus nephritis. Am J Kidney Dis 23:547–554PubMedGoogle Scholar
  29. Johnson H, Nived O (1990) Estimating the incidence of systemic lupus erythematosus in a defined population using multiple sources of retrieval. Br J Rheumatol 29:185–188PubMedGoogle Scholar
  30. Johnson AE, Gordon C, Palmer RG, Bacon PA (1995) The prevalence and incidence of systemic lupus erythematosus in Birmingham, England. Arthritis Rheum 38:551–558PubMedGoogle Scholar
  31. Jonsson R, Heyden G, Westberg NG (1984) Oral mucosal lesions in systemic lupus erythematosus. A clinical, histopathological and immunopathological study. J Rheumatol 11:38–42PubMedGoogle Scholar
  32. Johansson-Stephansson E, Koskimies S, Partanen J, Kariniemi AL (1989) Subacute cutaneous lupus erythematosus. Genetic markers and clinical and immunological findings in patients. Arch Dermatol 125:791–796CrossRefPubMedGoogle Scholar
  33. Karlson EW, Daltroy LH, Lew RA, Wright EA, Patridge AJ, Fossel AH, Roberts WN, Stern SH, Straaton KV, Wacholtz MC, Kavanaugh AF, Grosflam JM, Liang MH (1997) The relationship of socioeconomic status, race and modifiable risk factors to outcomes in patients with systemic lupus erythematosus. Arthritis Rheum 40:47–56PubMedGoogle Scholar
  34. Kellum RE, Haserike JR (1964) Systemic lupus erythematosus, a statistical evaluation of mortality based on a consecutive series of 229 patients. Arch Intern Med 113:200–207PubMedGoogle Scholar
  35. Le Bozec P, La Guyadec T, Crickx B (1994) Chronic lupus erythematosus in lupus disease. Retrospective study of 136 patients. Presse Med 23:1598–15602PubMedGoogle Scholar
  36. Lee P, Urowitz MB, Boockman AA, Koehler BE, Smythe HA, Gordon DA, Ogryzlo MA (1977) Systemic lupus erythematosus. A review of 110 cases with reference to nephritis, the nervous system, infections, aseptic necrosis and prognosis. Q J Med 46:1–32PubMedGoogle Scholar
  37. Maskarinec G, Katz AR (1995) Prevalence of systemic lupus erythematosus in Hawaii: Is there a difference between ethnic groups? Hawaii Med J 54:406–409PubMedGoogle Scholar
  38. Meddings J, Grennan MD (1980) The prevalence of systemic lupus erythematosus (SLE) in Dunedin. N Z Med J 91:205–206PubMedGoogle Scholar
  39. Merrell M, Shuldman LE (1955) Determination of prognosis in chronic disease, illustrated by systemic lupus erythematosus. J Chron Dis 1:12–32CrossRefPubMedGoogle Scholar
  40. McCarty DJ, Manzi S, Medsger TA, Ramsy-Goldman R, La Porte PE, Kwoh CK (1995) Incidence of systemic lupus erythematosus. Race and gender differences. Arthritis Rheum 38:1260–1270PubMedGoogle Scholar
  41. Michel M, Johanet C, Meyer C, Frances C, Wittke F, Michel C, Arfi S, Tournier-Lasserve E, Piette JC (2001) Familial lupus erythematosus: clinical and immunological features of 125 multiplex families. Medicine (Baltimore) 80:153–158CrossRefGoogle Scholar
  42. Michet CJ, McKenna CH, Elveback LR, Kaslow RA, Kurland LT (1985) Epidemiology of systemic lupus erythematosus and other connective tissue diseases in Rochester, Minnesota, 1950 through 1979. Mayo Clin Proc 60:105–113PubMedGoogle Scholar
  43. Nepom BS, Schaller JG (1984) Chilhood systemic lupus erythematosus. Prog Clin Rheumatol 1:33–69Google Scholar
  44. Nived O, Sturfelt G, Wolheim F (1985) Systemic lupus erythematosus in an adult population in southern Sweden: Incidence/prevalence and validity of ARA revised criteria. Br J Rheumatol 24:147–154PubMedGoogle Scholar
  45. Nossent JC (1992) Systemic lupus erythematosus on the Caribbean island of Curacao: An epidemiological investigation. Ann Rheum Dis 51:1197–1201PubMedGoogle Scholar
  46. O’Loughlin S, Schoeter AL, Jordan RE (1978) Chronic urticaria-like lesions in systemic lupus erythematosus. Arch Dermatol 114:879–883CrossRefPubMedGoogle Scholar
  47. Pistiner M, Wallace DJ, Nessim S, Metzger AL, Klinenberg JR (1991) Lupus erythematosus in the 1980s:a survey of 570 patients. Semin Arthritis Rheum 21:55–64CrossRefPubMedGoogle Scholar
  48. Provost TT, Zone JJ, Synowski D (1980) Unusual cutaneous manifestations of systemic lupus erythematosus: I. Urticaria-like lesions. Correlations with clinical and serological abnormalities. J Invest Dermatol 75:495–499CrossRefPubMedGoogle Scholar
  49. Reveille JD, Bartolucci A, Alarcón GS (1990) Prognosis in systemic lupus erythematosus. Negative impact of increasing age at onset, black race, and thrombocytopenia, as well as causes of death. Arthritis Rheum 33:37–48PubMedGoogle Scholar
  50. Rubin LA, Urowitz MB, Gladman DD (1985) Mortality in systemic lupus erythematosus: the bimodal pattern revisited. Q J Med 55:87–98PubMedGoogle Scholar
  51. Samanta A, Roy S, Feehally J, Symmons D (1992) The prevalence of diagnosed systemic lupus erythematosus in whites and Indian Asian immigrants in Leicester City, UK. Lupus 1(suppl):123Google Scholar
  52. Seleznick MJ, Fries JF (1991) Variables associated with decreased survival in systemic lupus erythematosus. Semin Arthritis Rheum 21:73–80CrossRefPubMedGoogle Scholar
  53. Siegel M, Lee SL (1973) The epidemiology of systemic lupus erythematosus. Semin Arthritis Rheum 3:1–54CrossRefPubMedGoogle Scholar
  54. Sontheimer RD, Maddison PJ, Reichlin M (1982) Serologic and HLA associations in subacute cutaneous lupus erythematosus, a clinical subset of lupus erythematosus. Ann Intern Med 97:664–671PubMedGoogle Scholar
  55. Sontheimer RD (1989) Subacute cutaneous lupus erythematosus: a decade’s perspective. Med Clin North Am 73:1073–1090PubMedGoogle Scholar
  56. Studenski S, Allen NB, Caldwell DS, Rice JR, Polisson RP (1987) Survival in systemic lupus erythematosus: A multivariate analysis of demographic factors. Arthritis Rheum 30:1326–1332PubMedGoogle Scholar
  57. Swaak AJ, Nossent J, Bronsveld W, Van Rooyen A, Nieuwenhuys EJ, Theuns L, Smeenk RJ (1989) Systemic lupus erythematosus: I. Outcome and survival: Dutch experience with 110 patients studied prospectively. Ann Rheum Dis 48:447–454PubMedGoogle Scholar
  58. Symmonds DPM (1995) Frequency of lupus in people of African origin. Lupus 4:176–178PubMedGoogle Scholar
  59. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield HF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for classification of SLE. Arthritis Rheum 25:1271–1272PubMedGoogle Scholar
  60. Ting CK, Hsieh KH (1992) A long term immunological study of childhood onset systemic lupus erythematosus. Ann Rheum Dis 51:45–51PubMedGoogle Scholar
  61. Uramoto KM, Michet CJ, Thumboo J, Sunku J, O’Fallon WM, Gabriel SE (1999) Trends in the incidence and mortality of systemic lupus erythematosus 1992. Arthritis Rheum 42:46–50CrossRefPubMedGoogle Scholar
  62. Urowitz MB, Bookman AAM, Koeler BE, Gordon DA, Smythe HA, Ogryzlo MA (1976) The bimodal mortality pattern of systemic lupus erythematosus. Am J Med 60:221–225CrossRefPubMedGoogle Scholar
  63. Villar J, Sánchez de Cos J, Pachón J, Maestre J, Pastor L, Martin M, Carneado J, Salgado V (1980) Lupus erythematosus disseminatus. Evaluation of the clinical and biological manifestations in 54 cases. Rev Clin Esp 159:21–26PubMedGoogle Scholar
  64. Vlachoyiannopoulos PG, Karassa FB, Karakostas KX, Drosos AA, Moutsopoulos HM (1993) Systemic lupus erythematosus in Greece. Clinical features, evolution and outcome: a descriptive analysis of 292 patients. Lupus 2:303–313PubMedGoogle Scholar
  65. Wallace DJ, Podell T, Weiner J, Klinenberg JR, Forouzesh S, Dubois EL (1981) Systemic lupus erythematosus: Experien cewith 609 patients. JAMA 245:934–938CrossRefPubMedGoogle Scholar
  66. Ward MM, Pyun E, Studenski S (1995a) Long-term survival in systemic lupus erythematosus. Patients characterisctics associated with poorer outcomes. Arthritis Rheum 38:274–283PubMedGoogle Scholar
  67. Ward MM, Pyun E, Studenski S (1995b) Causes of death in systemic lupus erythematosus. Long-term follow-up of an inception cohort. Arthritis Rheum 38:1492–1499PubMedGoogle Scholar
  68. Weinstein C, Miller MH, Axtens R, Buchanan R, Littlejohn GO (1987a) Livedo reticularis associated with increased titres of anticardiolipin antibodies in systemic lupus erythematosus. Arch Dermatol 123:596–600CrossRefPubMedGoogle Scholar
  69. Weinstein C, Miller MH, Axtens R, Littlejohn GO, Dorevitch AP, Buchanan R (1987b) Lupus and non-lupus cutaneous manifestations in systemic lupus erythematosus. Aust NZ J Med 17:501–506Google Scholar
  70. Worral JG, Snaith ML, Batchelor JR, Isenberg DA (1990) SLE: a rheumatological view. Analysis of the clinical features, serology and immunogenetics of 100 SLE patients during long-term follow-up. Q J Med 74:319–330PubMedGoogle Scholar
  71. Yell JA, Mbuagbaw J, Burge SM (1996) Cutaneous manifestations of systemic lupus erythematosus. Br J Dermatol 135:355–362CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 2005

Authors and Affiliations

  • Sònia Jiménez
  • Ricard Cervera
  • Miguel Ingelmo
  • Josep Font

There are no affiliations available

Personalised recommendations